Hyundai Bioscience Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	8,127	22,338	3,657	1,812	2,732	9,189
Short-Term Investments	29,673	17,739	-	10,000	16,000	13,010
Cash & Short-Term Investments	37,800	40,077	3,657	11,812	18,732	22,199
Cash Growth	-51.72%	996.00%	-69.04%	-36.94%	-15.62%	15.53%
Accounts Receivable	377.13	2,325	247.21	446.21	1,277	7,628
Other Receivables	75.37	96.01	85.09	19.54	50.97	55.15
Receivables	452.5	2,421	332.3	465.75	1,671	8,825
Inventory	1,158	1,137	1,076	2,588	2,946	3,350
Prepaid Expenses	175.31	138.25	381.52	204.45	568.66	337.92
Other Current Assets	407.57	217.44	1,364	92.36	93.33	138.65
Total Current Assets	39,994	43,990	6,810	15,163	24,012	34,851
Property, Plant & Equipment	3,319	3,652	3,583	2,904	6,376	6,073
Long-Term Investments	32,444	29,720	22,732	1,593	1,469	4,930
Other Intangible Assets	52,170	52,170	33,170	31,170	33,175	33,664
Other Long-Term Assets	517.7	506.6	498.05	914.36	1,268	929.34
Total Assets	129,104	130,739	67,705	52,792	67,327	80,528
Accounts Payable	377.59	498.72	555.33	430.52	686.72	191.61
Accrued Expenses	224.71	144.72	137.19	141.71	141.35	123.66
Short-Term Debt	14,683	17,264	25,832	5,400	5,900	14,014
Current Portion of Long-Term Debt	-	-	-	-	111.08	833.32
Current Portion of Leases	365.67	448.86	440.49	114.1	196.17	354.1
Other Current Liabilities	1,005	1,164	521.41	860.43	1,957	1,744
Total Current Liabilities	16,656	19,521	27,487	6,947	8,992	17,261
Long-Term Debt	-	-	-	-	-	111.08
Long-Term Leases	44.25	70.44	320.53	32.43	41.7	174.69
Pension & Post-Retirement Benefits	-	-	-	-	-	57.13
Long-Term Deferred Tax Liabilities	-	-	-	-	-	1,296
Other Long-Term Liabilities	424.5	421.13	459.04	541.56	57.23	57.23
Total Liabilities	17,124	20,012	28,266	7,521	9,091	18,957
Common Stock	48,253	48,020	19,911	19,905	19,841	19,330
Additional Paid-In Capital	100,935	96,832	39,806	38,827	145,476	133,406
Retained Earnings	-47,002	-41,851	-19,741	-12,812	-106,288	-90,481
Treasury Stock	-4.04	-4.04	-4.04	-4.04	-4.04	-4.04
Comprehensive Income & Other	9,798	7,729	-532.99	-645.72	-789.52	-680.57
Shareholders' Equity	111,979	110,726	39,438	45,271	58,235	61,571
Total Liabilities & Equity	129,104	130,739	67,705	52,792	67,327	80,528
Total Debt	15,093	17,784	26,593	5,547	6,249	15,488
Net Cash (Debt)	22,707	22,293	-22,937	6,265	12,483	6,712
Net Cash Growth	-59.35%	-	-	-49.81%	86.00%	-
Net Cash Per Share	235.94	237.11	-288.02	78.76	158.55	90.90
Filing Date Shares Outstanding	96.59	96.04	79.64	79.62	79.36	77.31
Total Common Shares Outstanding	96.59	96.04	79.64	79.62	79.36	77.31
Working Capital	23,338	24,469	-20,677	8,216	15,020	17,590
Book Value Per Share	1159.28	1152.93	495.22	568.62	733.80	796.36
Tangible Book Value	59,809	58,556	6,269	14,101	25,061	27,906
Tangible Book Value Per Share	619.18	609.72	78.71	177.11	315.78	360.94
Land	1,100	1,100	1,100	1,100	1,100	1,100
Buildings	3,834	3,834	3,834	3,834	5,190	5,190
Machinery	10,435	10,435	10,435	10,435	11,644	13,822
Construction In Progress	-	26.55	114.29	16	773.4	225